ADMA, ELISA

貨號 Cat. No.
K 7828
規格 Size
96 Tests
品牌 Brand
IDS

Description

































Article number: K 7828
Method: ELISA
Tests: 96 Tests
Matrix: EDTA Plasma, Serum, Citrate Plasma
Volume: 100 µl
Incubation time: 45min; 45min; 15-20h; 1h; 6-10min
Standards: 0.1-2.0 µmol/l







Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of NO synthesis, an enzyme that catalyses the production of nitric oxide from the amino acid arginine. Nitric oxide (NO) is one of the major endothelium-derived vasoactive mediators and is involved in the modulation of the blood flow and the blood pressure. Even small changes of the ADMA concentration alter vascular NO production, vascular tone, and systemic vascular resistence. Because of these properties NO has also been described as an “endogenous anti-atherosclerotic molecule”.

Elevated ADMA concentrations are found in patients with diabetes mellitus, hyperchoesterolemia, hypertension, pulmonary hypertension, peripheral arterial disease, chronic renal failure, preeclampsia or erectile dysfunction.

ADMA was found to predict cardiovascular risk independently of other variables. It has thus been concluded that ADMA is a novel cardiovascular risk factor.



Our ADMA ELISA determines ADMA in plasma and in Serum.

 

詢價 / 洽詢此產品

同品牌其他產品

回到產品列表

▲ LINE
諮詢